342 related articles for article (PubMed ID: 8556831)
1. Long-term ciclosporine A treatment in adults with minimal change nephrotic syndrome or focal segmental glomerulosclerosis.
Ittel TH; Clasen W; Fuhs M; Kindler J; Mihatsch MJ; Sieberth HG
Clin Nephrol; 1995 Sep; 44(3):156-62. PubMed ID: 8556831
[TBL] [Abstract][Full Text] [Related]
2. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M
Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
[TBL] [Abstract][Full Text] [Related]
3. Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated.
Ehrich JH; Geerlings C; Zivicnjak M; Franke D; Geerlings H; Gellermann J
Nephrol Dial Transplant; 2007 Aug; 22(8):2183-93. PubMed ID: 17504846
[TBL] [Abstract][Full Text] [Related]
4. Treatment of focal and segmental glomerulosclerosis in adults with tacrolimus monotherapy.
Duncan N; Dhaygude A; Owen J; Cairns TD; Griffith M; McLean AG; Palmer A; Taube D
Nephrol Dial Transplant; 2004 Dec; 19(12):3062-7. PubMed ID: 15507477
[TBL] [Abstract][Full Text] [Related]
5. Single-centre experience with cyclosporin in 106 children with idiopathic focal segmental glomerulosclerosis.
Mahmoud I; Basuni F; Sabry A; El-Husseini A; Hassan N; Ahmad NS; Elbaz M; Moustafa F; Sobh M
Nephrol Dial Transplant; 2005 Apr; 20(4):735-42. PubMed ID: 15772265
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of cyclosporine A in adult nephrotic syndrome with minimal change disease and focal-segmental glomerulosclerosis: a multicenter study in Korea.
Lee HY; Kim HS; Kang CM; Kim SG; Kim MJ
Clin Nephrol; 1995 Jun; 43(6):375-81. PubMed ID: 7554521
[TBL] [Abstract][Full Text] [Related]
7. Long-term Cyclosporine A (Sandimmun) therapy for steroid resistant nephrotic syndrome in children.
Sancewicz-Pach K; Słowiaczek E; Kwinta-Rybicka J; Wilkosz K; Drozdz D; Nowak J
Przegl Lek; 1996; 53(4):365-8. PubMed ID: 8711193
[TBL] [Abstract][Full Text] [Related]
8. Rituximab in minimal change nephropathy and focal segmental glomerulosclerosis: report of four cases and review of the literature.
Peters HP; van de Kar NC; Wetzels JF
Neth J Med; 2008 Nov; 66(10):408-15. PubMed ID: 19011266
[TBL] [Abstract][Full Text] [Related]
9. Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label, nonrandomized, retrospective study.
Ghiggeri GM; Catarsi P; Scolari F; Caridi G; Bertelli R; Carrea A; Sanna-Cherchi S; Emma F; Allegri L; Cancarini G; Rizzoni GF; Perfumo F
Clin Ther; 2004 Sep; 26(9):1411-8. PubMed ID: 15531003
[TBL] [Abstract][Full Text] [Related]
10. [Effect of cyclosporin A on renal function in patients with glomerulonephritis].
Heering P; Schneider A; Grabensee B; Plum J
Dtsch Med Wochenschr; 2001 Oct; 126(40):1093-8. PubMed ID: 11588659
[TBL] [Abstract][Full Text] [Related]
11. Serum permeability activity in steroid-resistant minimal change nephrotic syndrome is abolished by treatment of Hodgkin disease.
Aggarwal N; Batwara R; McCarthy ET; Sharma R; Sharma M; Savin VJ
Am J Kidney Dis; 2007 Nov; 50(5):826-9. PubMed ID: 17954296
[TBL] [Abstract][Full Text] [Related]
12. Treatment of steroid-resistant nephrotic syndrome with cyclosporine: study of 17 cases and a literature review.
Frassinetti Castelo Branco Camurça Fernandes P; Bezerra Da Silva G; De Sousa Barros FA; Costa Oliveira CM; Kubrusly M; Evangelista JB
J Nephrol; 2005; 18(6):711-20. PubMed ID: 16358229
[TBL] [Abstract][Full Text] [Related]
13. Treatment of corticoresistant idiopathic nephrotic syndrome in the adult: minimal change disease and focal segmental glomerulosclerosis.
Meyrier A; Simon P
Adv Nephrol Necker Hosp; 1988; 17():127-50. PubMed ID: 3124536
[TBL] [Abstract][Full Text] [Related]
14. Long-term treatment of focal segmental glomerulosclerosis in children with cyclosporine given as a single daily dose.
Chishti AS; Sorof JM; Brewer ED; Kale AS
Am J Kidney Dis; 2001 Oct; 38(4):754-60. PubMed ID: 11576878
[TBL] [Abstract][Full Text] [Related]
15. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
Li X; Li H; Ye H; Li Q; He X; Zhang X; Chen Y; Han F; He Q; Wang H; Chen J
Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporine in idiopathic nephrotic syndrome.
Ponticelli C
Immunopharmacol Immunotoxicol; 1993 Aug; 15(4):479-89. PubMed ID: 8227973
[TBL] [Abstract][Full Text] [Related]
17. Treatment of idiopathic nephrotic syndrome with cyclosporine A.
Meyrier A
J Nephrol; 1997; 10(1):14-24. PubMed ID: 9241620
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiology of minimal change nephrotic syndrome and focal segmental glomerulosclerosis.
Cho MH; Hong EH; Lee TH; Ko CW
Nephrology (Carlton); 2007 Dec; 12 Suppl 3():S11-4. PubMed ID: 17995521
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of the efficacy of cyclosporine A treatment in idiopathic nephrotic syndrome in children].
Wyszyńska T; Ksiazek J; Wieteska-Klimczak A; Gorzkowska-Paczwa M; Dorywalski T; Tysarowska A
Pol Merkur Lekarski; 2001 Aug; 11(62):140-3. PubMed ID: 11757213
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
Choudhry S; Bagga A; Hari P; Sharma S; Kalaivani M; Dinda A
Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]